NCT00791544View on ClinicalTrials.gov

Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Liver Carcinoma

Interventions

DRUG

AVE1642

intravenous infusion

DRUG

sorafenib

oral intake

DRUG

erlotinib

oral intake

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00791544 - Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma | Biotech Hunter | Biotech Hunter